Fusion event
HBV-chr2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reference genome
AF090842.1;AB033554.1;AB014381.1;M32138.1;AB032431.1;AB036910.1;AB064310;AY090454.1
End
119968076/119210500 (Hg38)
Nearest miRNA
hsa-mir-1285-2/Upstream/5489132; hsa-mir-10b/Downstream/8213037;
Upstream sequence
AACTCCTGGGCCTGGAAGAAACATCACGATTCAAGTGCTGCAGCACGAAAGAAGTTGAGGCTGGATTTGTATTCAGCTTGACTGTTTGTAAAGCACCATG
Downstream sequence
CACCATGCAACTGCCTTCAGTTCCttttttttttctttctttttttttttttttttttttgagatggagtttcgttcttgtcgcccaggctggagtgcaa
Zhao, L. H., et al.Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma. Nat Commun ,2016,7: 12992.